5803-62-3 - Names and Identifiers
Name | averantin
|
Synonyms | averantin AverantinDISCONTINUED 1,3,6,8-Tetrahydroxy-2-(1-hydroxyhexyl)-anthraquinone ANTHRAQUINONE,2-(1-HYDROXYHEXYL)-1,3,6,8-TETRAHYDROXY- (-)-1,3,6,8-Tetrahydroxy-2-(1-hydroxyhexyl)-9,10-anthracenedione 1,3,6,8-Tetrahydroxy-2-[(1S)-1-hydroxyhexyl]-9,10-anthracenedione
|
CAS | 5803-62-3
|
5803-62-3 - Physico-chemical Properties
Molecular Formula | C20H20O7
|
Molar Mass | 372.37 |
Density | 1.490±0.06 g/cm3(Predicted) |
Boling Point | 694.5±34.0 °C(Predicted) |
pKa | 6.04±0.20(Predicted) |
Storage Condition | 2-8℃ |
5803-62-3 - Introduction
averantin(averantin) is a compound with the chemical formula C24H22O6. The following is a description of the nature, use, formulation and safety information of averantin:
Nature:
- averantin is a green crystalline solid.
-It is dissolved in some organic solvents, such as chloroform and dimethyl sulfoxide.
-Its melting point is 280-281 ° C.
Use:
- averantin is commonly used as a fluorescent detector and redox reagent in the laboratory.
-It can also be used as a catalyst in organic synthesis.
Method:
The preparation method of-averantin is more complicated and is usually synthesized by synthetic routes. One of the synthetic methods is to synthesize averantin by a series of functional group transfers and subsequent reactions starting from the aromatic amine, butanone and oxazole skeletons.
Safety Information:
-Specific safety information and toxicity data on averantin are limited.
-As with all chemical substances, general safety practices in laboratory and industrial applications should be followed.
-When using averantin, you must wear appropriate personal protective equipment, such as laboratory gloves and goggles.
-In case of contact with skin or eyes, rinse immediately with plenty of water for 15 minutes and seek medical advice.
Please note that the exact use and preparation process of averantin may need to be determined by specific circumstances, so professional recommendations and operating guidelines should be followed.
Last Update:2024-04-10 22:29:15